Stock Events

Stock Events

Mimedx Group 

$4.57
37
+$0.14+3.16% Friday 20:00
-$0.02-0.44%Friday 23:30After hours

Statistics

Day High
4.57
Day Low
4.56
52W High
7.97
52W Low
3.03
Volume
15,523
Avg. Volume
-
Mkt Cap
666.13M
P/E Ratio
20.55
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.1
-0.03
0.04
0.11
Expected EPS
-0.014
Actual EPS
N/A

Financials

11.6%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
418.63MRevenue
48.58MNet Income

Analyst Ratings

7.33Average Price Target
The highest estimate is 8.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
67%
Hold
33%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MDXG. It's not an investment recommendation.
Microsoft
10
MSFT
NVIDIA
10
NVDA
Amazon
9
AMZN
Alphabet
8
GOOGL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.77B
Medtronic plc offers products for wound healing and tissue regeneration, competing in the same space as MiMedx with a broad range of medical devices and therapies.
Baxter International
BAX
Mkt Cap13.51B
Baxter International Inc. provides advanced surgical, wound care, and regenerative medicine products, directly competing with MiMedx in the wound care market.
Sanara MedTech
SMTI
Mkt Cap317.63M
Sanara MedTech Inc. focuses on wound and skincare products, directly competing with MiMedx in the development and marketing of regenerative medicine and tissue products.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson offers a wide range of healthcare products, including wound care solutions through its subsidiaries, competing with MiMedx in the healthcare and regenerative medicine sectors.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation specializes in medical devices, including surgical equipment and regenerative products, competing with MiMedx in the market for surgical and wound care solutions.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie Inc. engages in the development of pharmaceuticals and biologics that compete in the broader healthcare market, including areas such as regenerative medicine, indirectly competing with MiMedx.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet Holdings, Inc. offers musculoskeletal healthcare products, including surgical solutions and therapies for wound care, competing with MiMedx in the regenerative medicine and orthopedics market.

About

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
Show more...
CEO
Joseph H. Capper
Employees
808
Country
United States
ISIN
US6024961012

Listings

MU
DE
MXE.MU
STU
DE
MXE.STU
XNAS
US
MDXG
BOATS
BOATS
MDXG.BOATS

0 Comments

Share your thoughts

FAQ

What is Mimedx Group stock price today?▼
The current price of MDXG is $4.57 USD — it has increased by +3.16% in the past 24 hours. Watch Mimedx Group stock price performance more closely on the chart.
What is Mimedx Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Mimedx Group stocks are traded under the ticker MDXG.
Is Mimedx Group stock price growing?▼
MDXG stock has risen by +1.56% compared to the previous week, the month change is a +9.86% rise, over the last year Mimedx Group has showed a -35.99% decrease.
What is Mimedx Group market cap?▼
Today Mimedx Group has the market capitalization of 666.13M
When is the next Mimedx Group earnings date?▼
Mimedx Group is going to release the next earnings report on November 04, 2026.
What were Mimedx Group earnings last quarter?▼
MDXG earnings for the last quarter are -0.1 USD per share, whereas the estimation was -0.05 USD resulting in a -102.02% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Mimedx Group revenue for the last year?▼
Mimedx Group revenue for the last year amounts to 418.63M USD.
What is Mimedx Group net income for the last year?▼
MDXG net income for the last year is 48.58M USD.
How many employees does Mimedx Group have?▼
As of September 05, 2026, the company has 808 employees.
In which sector is Mimedx Group located?▼
Mimedx Group operates in the Health & Wellness sector.
When did Mimedx Group complete a stock split?▼
The last stock split for Mimedx Group was on April 02, 2008 with a ratio of 0.3234758:1.
Where is Mimedx Group headquartered?▼
Mimedx Group is headquartered in MARIETTA, United States.